Gilead Sciences (NASDAQ:GILD) is preparing to release its quarterly earnings on Thursday, 2025-08-07. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Gilead Sciences to report an earnings per share (EPS) of $1.95.
Investors in Gilead Sciences are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It’s worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Past Earnings Performance
During the last quarter, the company reported an EPS beat by $0.05, leading to a 2.81% drop in the share price on the subsequent day.
Here’s a look at Gilead Sciences’s past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | 1.76 | 1.7 | 1.55 | 1.60 |
| EPS Actual | 1.81 | 1.9 | 2.02 | 2.01 |
| Price Change % | -3.0% | 7.000000000000001% | 7.000000000000001% | -3.0% |
Tracking Gilead Sciences’s Stock Performance
Shares of Gilead Sciences were trading at $112.46 as of August 05. Over the last 52-week period, shares are up 47.16%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analysts’ Take on Gilead Sciences
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Gilead Sciences.
Gilead Sciences has received a total of 1 ratings from analysts, with the consensus rating as Buy. …